The efficacy and safety of immune checkpoint inhibitors combined with antiangiogenic drugs in renal cell carcinomas: a systematic review and meta-analysis

BACKGROUND: The treatment of solid malignant tumors using immune checkpoint inhibitors (ICIs) combined with antiangiogenic drugs, has gradually become an active field of clinical research. However, the results are inconsistent. Therefore, we designed this meta-analysis to evaluate the efficacy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qian, Li, Jiayi, Zhang, Chi, Tang, Sheng, Ren, Qinglan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798721/
https://www.ncbi.nlm.nih.gov/pubmed/35117287
http://dx.doi.org/10.21037/tcr-20-1975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798721/
https://www.ncbi.nlm.nih.gov/pubmed/35117287
http://dx.doi.org/10.21037/tcr-20-1975

Ejemplares similares